Contrato Sara Borrell 2022. GOMES MARQUÉS, PATRICE
Datos básicos
- Código:
- CD22/00045
- Protocolo:
- CD22/00045
- EUDRACT:
- NCT:
- Centro:
- Dotación:
- 95.000,00 €
- Año de incio:
- 2023
- Año de finalización:
- 2026
Documentos
- No hay documentos
Participantes
Grupos
Financiadores - Promotores
Resultados del Ensayo Clínico
Access to liver transplant for women in Spain: a national registry analysis
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Access to liver transplant for women in Spain: a national registry analysis
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Addressing the Burden and Management Strategies for Disparities and Inequities Among Liver Transplant Professionals: The ILTS Experience.
Andacoglu, Oya; (...); Selzner, Nazia
Article. 10.3389/ti.2023.11240. 2023
Anesthesia and Critical Care for the Prediction and Prevention for Small-for-size Syndrome: Guidelines from the ILTS-iLDLT-LTSI Consensus Conference.
Chadha, Ryan; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004803. 2023
CMV reactivation (rCMV) is associated with lower hepatocellular carcinoma (HCC) recurrence after liver transplatatoin (LT)
Aguilera, V.; (...); Berenguer, M.
Meeting Abstract. 2023
CMV reactivation after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Garcia-Garcia, Sonia; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley KV; (...); Villamil A
Article. 10.14309/ajg.0000000000003029. 2024
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls.
Kowdley, Kris V; (...); Villamil, Alejandra
Article. 10.14309/ajg.0000000000003153. 2024
Cytomegalovirus reactivation is associated with lower hepatocelullar carcinoma recurrence rates after liver transplantation
Aguilera Sancho, Victoria; (...); Rodriguez-Peralvarez, Manuel
Meeting Abstract. 2023
Cytomegalovirus specific polyfunctional t-cells control CMV reactivation, after liver transplantation
Carvalho-Gomes, Angela; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2024
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis (vol 22, pg 2062, 2024)
De Vincentis, A.; (...); Conde, Isabel
Correction. 2025
Development and validation of a scoring system to predict response to obeticholic acid in primary biliary cholangitis.
De Vincentis, Antonio; (...); Carbone, Marco
Article. 10.1016/j.cgh.2024.05.008. 2024
Does colectomy improve survival in patients with ulcerative colitis undergoing liver transplant for autoimmune liver diseases?
Trapero-Marugan, M.; (...); Cuervas-Mons, V.
Meeting Abstract. 2023
Early liver transplantation for acute alcoholic hepatitis In a spanish liver transplant center
Aguilera Sancho, Victoria; (...); Berenguer, Marina
Meeting Abstract. 2023
EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
EFFICACY OF OBETICHOLIC ACID (OCA) VS PLACEBO AND EXTERNAL CONTROL (EC) ON CLINICAL OUTCOMES IN PRIMARY BILIARY CHOLANGITIS (PBC)
Kowdley, Kris V.; (...); Villamil, Alejandra
Meeting Abstract. 2023
European Society for Organ Transplantation Consensus Statement on Biomarkers in Liver Transplantation.
Berenguer M; (...); Zubair H
Article. 10.3389/ti.2023.11358. 2023
Excess waitlist mortality and survival benefit of liver transplantation for patients with severe acute-on-chronic liver failure: Interim results of the CHANCE study
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
Exchangeable copper for patients with Wilson disease at follow-up: rethinking normal ranges or changing methodology.
Marino, Zoe; (...); Berenguer, Marina
Article. 10.1097/HEP.0000000000001105. 2024
EXCHANGEABLE COPPER QUANTIFICATION FELLS BELOW NORMAL RANGE IN A HIGH PROPORTION OF PATIENTS WITH WILSON DISEASE DURING FOLLOW-UP
Mendez, Zoe Marino; (...); Berenguer, Marina
Meeting Abstract. 2024
Exchangeable copper quantification fells belownormal range in a high proportion of patients withWilson disease during follow-up
Marino, Zoe; (...); Berenguer, Marina
Meeting Abstract. 2024
Exploring pregnancy, breastfeeding and contraception among women with Wilson disease in Spain: results from the Spanish Wilson registry
Romero-Gutierrez, Marta; (...); Marino, Zoe
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma (HCC) in HCV SVR F3-F4 patients
Sahuco, Ivan; (...); Berenguer, Marina
Meeting Abstract. 2023
External validation of models to predict hepatocellular carcinoma in Hepatitis C Virus cured F3-F4 patients.
Carvalho-Gomes Â; (...); Berenguer M
Article. 10.1002/ueg2.12571. 2024
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, Laura; (...); Berenguer, Marina
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately detecting recurrent hepatic steatosis and fibrosis after liver transplantation for metabolic dysfunction-associated steatohepatitis
Martinez-Arenas, L.; (...); Berenguer, M.
Meeting Abstract. 2024
FibroScan compared to liver biopsy for accurately staging recurrent hepatic steatosis and fibrosis after transplantation for MASH.
Martinez-Arenas, Laura; (...); Berenguer, Marina
Article. 10.1111/liv.16085. 2024
First nationwide genetic study on Wilson disease (Spanish Wilson registry): high diversity in mutations and in use of genetic evaluation, association with clinical data and influence on diagnosis and health costs
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Frailty changes after liver transplantation in the Spanish setting. Results from a Spanish multicentre prospective cohort study
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
Frailty Changes After Liver Transplantation. Results From a Spanish Multicenter Prospective Cohort Study
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1097/TXD.0000000000001599. 2024
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, Isabel; (...); Aguilera Sancho, Victoria
Meeting Abstract. 2023
Gender differences in liver transplantation (LT) for acute liver failure (ALF) in a multicentre ALF-LT Spanish cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Health-Related Quality of Life in Patients Living with Wilson Disease in Spain: A Cross-Sectional Observational Study.
Marino, Zoe; (...); Anguera, Anna
Article. 10.3390/jcm12144823. 2023
Hepatic nerve endings are rewired by cholestatic injury to connect inflamed lymphatics to sites of ductular remodelling
Noon, Luke; (...); Lloyd, Alison
Meeting Abstract. 2023
HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity
Andrade, Rita; (...); Cardoso, Joana
Article. 10.3390/cancers17030500. 2025
Impact of suffering Wilson disease in Spain: an observational cross-sectional multicenter study
Marino, Zoe; (...); Anguera, Anna
Meeting Abstract. 2023
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, Isabel Terol; (...); Sancho, Victoria Aguilera
Meeting Abstract. 2023
Incidence of de novo tumors after liver transplantation (LT) in HIV infected is similar to non-HIV patients: a single center comparative study
Chafer, I. Terol; (...); Sancho-Tello, M. V. Aguilera
Meeting Abstract. 2023
International Living Donor Liver Transplant Registry - Initial progress towards transparent reporting of outcomes
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
LATTICE radiotherapy: A one institution experience
Solero, I.; (...); Conde, A.
Meeting Abstract. 2023
Launch of the International Living Donor Liver Transplantation Outcomes Registry.
Staubli, Sebastian; (...); Rela, Mohamed
Letter. 10.1016/S2468-1253(23)00185-1. 2023
Lessons from population genomics for Wilson disease: Prevalence, penetrance of mutations, clinical implications and design of regional screening programmes
Alonso Castellano, Pablo; (...); Garcia-Villarreal, Luis
Meeting Abstract. 2023
Liver Transplantation 2023: Status Report, Current and Future Challenges.
Terrault, Norah A; (...); Heimbach, Julie
Article. 10.1016/j.cgh.2023.04.005. 2023
Longitudinal outcomes of obeticholic acid therapy in ursodiol-nonresponsive primary biliary cholangitis: Stratifying the impact of add-on fibrates in real-world practice.
Gomez, E; (...); Fernandez-Rodriguez, C M
Article. 10.1111/apt.18004. 2024
Long-term prospective follow-up of a primary biliary cholangitis (PBC) multicenter cohort treated with Obeticholic Acid (OCA). Interaction effect of triple therapy with fibrates
Gomez-Dominguez, Elena; (...); Fernandez-Rodriguez, Conrado
Meeting Abstract. 2023
Low penetrance of frequent ATP7B mutations explains the low prevalence of Wilson disease. Lessons from real-life registries.
Alonso-Castellano, Pablo; (...); Garcia-Villarreal, Luis
Article. 10.1016/j.dld.2024.09.002. 2024
Main clinical characteristics and evolutionary events among patients suffering Wilson disease in Spain: first results from the Spanish Wilson registry
Marino, Zoe; (...); Castillo, Pilar
Meeting Abstract. 2023
Management of cytomegalovirus in adult solid organ transplant patients: GESITRA-IC-SEIMC, CIBERINFEC, and SET recommendations update.
Ruiz-Arabi, Elisa; (...); Aguado, Jose Maria
Article. 10.1016/j.trre.2024.100875. 2024
Management of Established Small-for-size Syndrome in Post Living Donor Liver Transplantation: Medical, Radiological, and Surgical Interventions: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kirchner, Varvara A.; (...); Rela, Mohamed
Article. 10.1097/TP.0000000000004771. 2023
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors
Martin-Mateos, R.; (...); Albillos, A.
Meeting Abstract. 2024
Multidrug-resistant bacterial infections after liver transplantation: prevalence, impact, and risk factors.
Martin-Mateos R; (...); Albillos A
Article. 10.1016/j.jhep.2024.02.023. 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Deek MP; (...); Sweeney C
Article. 10.1016/j.euo.2024.03.010. 2024
Nutritional status in hepatic encephalopathy and transjugular intrahepatic portosystemic shunt-TIPS, and strategies to improve the outcomes
Review. 10.51821/86.2.11430. 2023
Optimization of treatment in patients with primary biliary cholangitis: Gamma-glutamyl transferase levels as an early prognostic marker for ursodeoxycholic acid response. Results from the ColHai registry
Fernandez-Gordon Sanchez, Flor M.; (...); Gomez-Dominguez, Elena
Meeting Abstract. 2024
Overcoming barriers to care for Delta infected patients
Bono, Ariadna; (...); Berenguer, Marina
Meeting Abstract. 2023
Paediatric solid organ transplant recipients (SOTR) demonstrate greater serological response to initial SARS-CoV-2 vaccination than adult SOTR, and comparable rates of antibody degradation
Pilar Ballester, Maria; (...); Nicastro, Emanuele
Meeting Abstract. 2024
Post Living Donor Liver Transplantation Small-for-size Syndrome: Definitions, Timelines, Biochemical, and Clinical Factors for Diagnosis: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Kow, Alfred Wei Chieh; (...); Ikegami, Toru
Article. 10.1097/TP.0000000000004770. 2023
PREDICTION OF BIOCHEMICAL RESPONSE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS TREATED WITH OBETICHOLIC ACID: DERIVATION AND EXTERNAL VALIDATION OF THE OCA RESPONSE SCORE (ORS)
De Vincentis, Antonio; (...); Carbone, Marco
Meeting Abstract. 2023
Predictive factors for decompensating events in patients with cirrhosis with primary biliary cholangitis under different lines of therapy.
Ampuero J; (...); Fernández-Rodríguez C
Article. 10.1097/HEP.0000000000000826. 2024
Preventing Small-for-size Syndrome in Living Donor Liver Transplantation: Guidelines From the ILTS-iLDLT-LTSI Consensus Conference.
Hakeem AR; (...); Rela M
Article. 10.1097/TP.0000000000004769. 2023
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2022 Clinical Practice Guideline.
Awan, Ahmed Arslan Yousuf; (...); Jadoul, Michel
Article. 10.7326/M23-2391. 2023
Primary sclerosing cholangitis as an indication for liver transplantation. Results and conditioning factors: relationship with associated intestinal pathology
Fernandez, Ainhoa; (...); Salcedo, Magdalena
Meeting Abstract. 2023
Primary Sclerosing Cholangitis: Gender Effects in Valencia's Low-Prevalence Region.
Minguez, Alejandro; (...); Berenguer, Marina
Article. 10.1007/s10620-024-08368-y. 2024
Profile of plasma microRNAs as a potential biomarker of Wilson's disease.
Sanchez-Monteagudo, Ana; (...); Espinos, Carmen
Article. 10.1007/s00535-024-02135-6. 2024
Prognosticating hepatocellular carcinoma before and after liver transplantation with HepatoPredict
Silva, Silvia Gomes; (...); Cardoso, Joana
Meeting Abstract. 2024
Protocol for an International Living Donor Liver Transplant Registry ! LDLTregistry.org
Turner, B.; (...); Salinas, C. Hidalgo
Meeting Abstract. 2023
Re-irradiation in NSCLC High-dose RT: Control, Survival and Toxicity
Germain, J.; (...); Conde, A.
Meeting Abstract. 2023
Reproductive and pregnancy control in Wilson disease patients in Spain.
Romero-Gutiérrez M; (...); Mariño Z
Article. 10.1097/MEG.0000000000002831. 2024
Risk of decompensated cirrhosis in patients with primary biliary cholangitis under first, second and third-line therapies
Lucena, Ana; (...); Ampuero, Javier
Meeting Abstract. 2023
Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebocontrolled trial
Puente Sanchez, Angela; (...); Garcia Pagan, Juan Carlos
Meeting Abstract. 2023
Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant.
Mehta, Gautam; (...); Jalan, Rajiv
Article. 10.1097/HC9.0000000000000273. 2023
Significant heterogeneity in the diagnosis and long-term management of Wilson disease: Results from a large multicenter Spanish study
Berenguer, Marina; (...); GEMHEP
Article. 10.1016/j.gastrohep.2022.10.018. 2023
Similar rates of liver transplantation (LT) for acute liver failure (ALF) but changes in patient profiles in a Spanish multicentre cohort
Conde, I.; (...); Aguilera, V.
Meeting Abstract. 2023
Survey to evaluate the implementation of the recommendations on the comprehensive diagnosis of viral hepatitis in a single extraction: where are we?
Cabezas, Joaquin; (...); Crespo, Javier
Meeting Abstract. 2023
SURVEY TO EVALUATE THE IMPLEMENTATION OF THE RECOMMENDATIONS ON THE COMPREHENSIVE DIAGNOSIS OF VIRAL HEPATITIS IN A SINGLE EXTRACTION: WHERE ARE WE?
Cabezas, Joaquin; (...); Crespo Garcia, Javier
Meeting Abstract. 2023
The concentration of HDV-RNA correlates with the probability of developing clinical events in patients with chronic hepatitis D
Palom, Adriana; (...); Buti, Maria
Meeting Abstract. 2024
The global prospective observational study to evaluate the role of 'liver transplantation in patients with cirrhosis and severe acute-on-chronic liver failure (CHANCE)': study design, demographics and overall outcome
Gustot, Thierry; (...); Jalan, Rajiv
Meeting Abstract. 2024
Transaminase Pattern Over Time Is Not Associated with a More Aggressive Hepatic Evolution: Results from the AEEH Wilson Registry
Berenguer, Marina; (...); Marino, Zoe
Meeting Abstract. 2024
Transplantation: A Priority in the Healthcare Agenda.
Muller E; (...); Potena L
Article. 10.1097/TP.0000000000005182. 2025
Use of HBsAg-positive donors in liver transplantation: an ILTS-EASLAASLD multisociety survey
Vinaixa, C.; (...); Terrault, N.
Meeting Abstract. 2024
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey.
Vinaixa, Carmen; (...); Berenguer, Marina
Article. 10.1097/LVT.0000000000000432. 2024
Validation of MELD3.0 in 2 centers from different continents.
Tejedor M; (...); Berenguer M
Article. 10.1097/HC9.0000000000000504. 2024
Validation of MELD3.0 in two centres from different continents
Tejedor Bravo, Marta; (...); Berenguer, Marina
Meeting Abstract. 2023
Validation of MELD3.0 in two centres from different continents
Tejedor, M.; (...); Berenguer, M.
Meeting Abstract. 2023
Validation of the liver frailty index as an adverse outcome predictor in the spanish liver transplant setting. Results from a spanish multicentre prospective cohort study.
Puchades, L.; (...); Berenguer, M.
Meeting Abstract. 2023
Variation in global living donor liver transplant surgical technique - early data from the International Living Donor Liver Transplant Registry (LDLTregistry.org)
Kantsedikas, I.; (...); Rela, M.
Meeting Abstract. 2024
Variation in global living donor liver transplant surgical technique: Early data from the International Living Donor Liver Transplant Registry
Kantsedikas, Ilya; (...); Rela, Mohamed
Meeting Abstract. 10.1097/01.tp.0001066152.18661.c6. 2024
Very low access to early liver transplantation (LT) for acute alcoholic hepatitis (AAH) in a setting of social psychiatric contraindications
Garcia Garcia, S.; (...); Aguilera, V.
Meeting Abstract. 2023
Waiting time dictates impact of frailty: A Spanish multicenter prospective study.
Puchades, Lorena; (...); Berenguer, Marina
Article. 10.1016/j.jhepr.2023.100840. 2023
Women are also disadvantaged in accessing transplant outside the United States: analysis of the spanish liver transplantation registry
Tejedor, Marta; (...); Berenguer, Marina
Meeting Abstract. 2024
Women Are Also Disadvantaged in Accessing Transplant Outside the United States: Analysis of the Spanish Liver Transplantation Registry.
Tejedor, Marta; (...); Berenguer, Marina
Article. 10.3389/ti.2024.12732. 2024